SBIR Eligibility For Venture Cap Encouraged By NVCA Data Gathering Effort
This article was originally published in The Gray Sheet
Executive Summary
The National Venture Capital Association will attempt to quantify the total number of lives saved by VC-backed technologies in a report on the role of early-stage funding in medical device innovation
You may also be interested in...
NIH Director Sides With Venture Capital-Backed Firms On SBIR Awards
Biotech industry representatives cited a recent letter by NIH Director Elias Zerhouni during a July 27 congressional hearing in which they pressed lawmakers to repeal restrictions that disqualify some small businesses from competing for government research grants
NIH Director Sides With Venture Capital-Backed Firms On SBIR Awards
Biotech industry representatives cited a recent letter by NIH Director Elias Zerhouni during a July 27 congressional hearing in which they pressed lawmakers to repeal restrictions that disqualify some small businesses from competing for government research grants
Small Business Administration proposed rule
Restructuring small business size standards, better measurement of employees for grant-eligibility and participation by venture capital are topics on which SBA seeks public comment, following a Dec. 3 proposed rule. The Medical Device Manufacturers Associations and the National Venture Capital Association have bristled at the restrictions on venture capital assistance, which could exclude from Small Business Innovation Research grants companies that are majority-owned by VC firms (1"The Gray Sheet" Dec. 22, 2003, p. 13). SBA's proposed rule notes that a majority of commenters endorsed an earlier proposal in March that sought to alter size requirements for SBIR grants. Comments on the December proposal are due Feb. 1. With the consolidated appropriations bill's passage into law Dec. 8, SBA was reauthorized for two years...